Categories
Business Computers & Software Education Employment India

The Test Tribe to Host the Biggest Virtual Testing Event on Saturday, 8th October

India’s Largest Testing Community, The Test Tribe is all set to host a 2-day global software testing binge, TestFlix on 8th October and 9th October. TestFlix will be a two-day Conference with over 16 hours of content by 60+ global speakers from top tech companies like Apple, Meta, Google, and Thoughtworks.

The event will have a global line-up of speakers and attendees. As reported by The Test Tribe, Testflix has already received close to 12,000 registrations from 105 countries.

The speakers will be sharing their experiences and knowledge on a range of topics like test automation, agile, performance testing, mobile testing, DevOps, AI & ML in testing, and more. The event will also have a special focus on the latest trends and challenges in the testing industry.

“With TestFlix, our aim is fairly simple, to bring global thought leaders and community members together on one platform. That’s why we keep it as Free for testers, so that the cost does not become a deterrent for testers across the world to learn from the experts. In the last 2 editions we have hosted 200+ global thought leaders and hosted 11000 testers in total”, Says Mahesh Chikane, the founder of The Test Tribe

With an impressive line-up of speakers and content, TestFlix is sure to be a must-attend event for all Software Quality professionals. So, mark your calendars and save the date for 8th October!

The registrations are still open and can be done through this link. https://www.thetesttribe.com/testflix-2022/

About The Company:

The Test Tribe is an EdTech Community Startup with one of the World’s leading communities for testers. The community is devoted to giving testing and QA the recognition it deserves, while empowering testers to collaborate, learn and grow together. The vibrant online community, range of events, and EdTech Products provide an excellent platform for testers to share their knowledge and expertise. Their aim is co-create smarter, prouder and confident Testers so the World sees better quality Tech. Over the last few years, The Test Tribe has done 160+ events and touched the lives of 50000+ testers.

Categories
Employment Health & Medicine Human Resources India Pharmaceuticals & Biotech

A Sneak Peek Into the Flourishing Outsourced Drug Trials in India

Over the past decade, the big pharmaceutical companies have moved their clinical testings abroad. Among all others, India has become a choice destination—a goldmine for their operations.

A majority of the research on new drugs is carried out in the more developed countries (MDC). However, according to a recent study by Rabo India Finance, a subsidiary of Rabobank of the Netherlands, there is a 50-60 percent estimated cost of savings if the trials are held in developing countries. The contract research market is worth an estimated $10 billion while the international clinical trial business is worth a whopping $40 billion.

Just as India has become the premium destination for tech giants to outsource their software development needs, the country has also become a hot-spot for a clinical trial like no other country. The country is a fertile ground for this practice with copious, low-cost and English-speaking medical staff, a functional medical infrastructure, heartwarming reception towards foreign industry, and, perhaps, the most important factor: millions of poor citizens ever willing to try out new drugs. 

Despite the economic revenue it accrues to the country’s GDP, to an estimated $2 billion by 2021, there’s been a public outcry in some quarters against clinical trials in India, more so because it has slapped on the country, the denigrating nickname of “guinea pigs to the world”.

The major concern of most critics against this practice stems from the fear that U.S. pharmaceutical companies may be eluding regulatory controls by outsourcing trials to India rather than conducting them in the United States. Speaking about this, Tripti Tandon of Lawyers Collective, a legal group for HIV-positive people, said: “It is important that the regulations take into consideration the rights of the people on whom the tests are being carried out.” Lending his voice, Mira Shiva of the Voluntary Health Association of India said: Post-marketing surveillance needs to be strengthened to ensure that fake data has not been used to get a drug into the market.”

Consequently, Indian health authorities have posited, times without number, that they are on top of the situation. However, this may not be entirely true. In 2015 the Regional Cancer Centre (RCC), teaming up with the Johns Hopkins University, USA, conducted some cancer drug trials. Cancer patients were injected with experimental drugs without due clearance from the appropriate authorities. A special committee investigated the incident, and the matter dismissed.